• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Authors' Reply to Alain Braillon's Comment on "Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence".

作者信息

Sinclair Julia M A, Chambers Sophia E, Baldwin David S

机构信息

Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

University Department of Psychiatry, Academic Centre, College Keep, 4-12 Terminus Terrace, Southampton, SO14 3DT, UK.

出版信息

Drug Saf. 2016 Nov;39(11):1153-1154. doi: 10.1007/s40264-016-0448-3.

DOI:10.1007/s40264-016-0448-3
PMID:27503285
Abstract
摘要

相似文献

1
Authors' Reply to Alain Braillon's Comment on "Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence".作者对阿兰·布拉永对《酒精依赖药物治疗的安全性和耐受性：证据综合综述》的评论的回复。
Drug Saf. 2016 Nov;39(11):1153-1154. doi: 10.1007/s40264-016-0448-3.
2
Authors' Reply to Alain Braillon's Comment on "Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: An example with baclofen and alcohol dependence in France''.作者对阿兰·布拉illon关于“前瞻性区域药物警戒系统与国家自发报告在收集有关超说明书用药实践的安全数据方面的比较：以法国巴氯芬与酒精依赖为例”的评论的回复
Drug Saf. 2017 Apr;40(4):361-362. doi: 10.1007/s40264-017-0513-6.
3
Authors' Reply to Alain Braillon's Comment on "The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project".
Drug Saf. 2016 Apr;39(4):367-8. doi: 10.1007/s40264-016-0404-2.
4
Authors' Response to Braillon's Comment on: "Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring".作者对布拉永对《使用抗抑郁药患者发生心律失常和心源性猝死危险因素的证据有限：荷兰心电图监测共识》的评论的回应
Drug Saf. 2018 Dec;41(12):1417-1418. doi: 10.1007/s40264-018-0716-5.
5
Comment on: "Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence".评论：“酒精依赖药物治疗的安全性与耐受性：证据综合综述”
Drug Saf. 2016 Nov;39(11):1151-1152. doi: 10.1007/s40264-016-0447-4.
6
Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.酒精依赖药物治疗的安全性与耐受性：证据综合综述
Drug Saf. 2016 Jul;39(7):627-45. doi: 10.1007/s40264-016-0416-y.
7
[Depression and alcoholism: a potential familial-genetic relationship].
Psychiatr Pol. 1996 Mar-Apr;30(2):281-96.
8
Aberrations of an IR chopping secondary: authors' reply to comment 2 and continuation of authors' reply to comment 1.红外斩波副镜的像差：作者对评论2的回复以及对评论1回复的延续
Appl Opt. 1985 Apr 1;24(7):944. doi: 10.1364/AO.24.000944.
9
Pregabalin for alcohol dependence: a critical review of the literature.普瑞巴林治疗酒精依赖：文献综述。
Adv Ther. 2012 Nov;29(11):947-57. doi: 10.1007/s12325-012-0061-5. Epub 2012 Nov 5.
10
Neurobehavioral aspects of the pharmacotherapy of alcohol dependence.酒精依赖药物治疗的神经行为学方面
Clin Neurosci. 1995;3(3):145-54.

引用本文的文献

1
Impact of the aldehyde dehydrogenase 2 (ALDH2) gene testing on alcohol drinking behaviors among the Chinese Han population: study protocol of a single-center, open-label, randomized, controlled clinical trial.乙醛脱氢酶2（ALDH2）基因检测对中国汉族人群饮酒行为的影响：一项单中心、开放标签、随机对照临床试验的研究方案
Trials. 2025 May 7;26(1):147. doi: 10.1186/s13063-025-08851-5.

本文引用的文献

1
Comment on: "Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence".评论：“酒精依赖药物治疗的安全性与耐受性：证据综合综述”
Drug Saf. 2016 Nov;39(11):1151-1152. doi: 10.1007/s40264-016-0447-4.
2
Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence.酒精依赖药物治疗的安全性与耐受性：证据综合综述
Drug Saf. 2016 Jul;39(7):627-45. doi: 10.1007/s40264-016-0416-y.
3
Nalmefene in alcohol misuse: junk evaluation by the European Medicines Agency.
纳美芬用于酒精滥用：欧洲药品管理局的垃圾评估
BMJ. 2014 Mar 10;348:g2017. doi: 10.1136/bmj.g2017.
4
Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies.按需纳美芬治疗至少具有高饮酒风险水平的酒精依赖患者的疗效：两项随机对照 6 个月研究的亚组分析结果。
Alcohol Alcohol. 2013 Sep-Oct;48(5):570-8. doi: 10.1093/alcalc/agt061. Epub 2013 Jul 19.
5
A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.纳美芬按需使用治疗酒精依赖患者的随机、双盲、安慰剂对照疗效研究。
Eur Neuropsychopharmacol. 2013 Nov;23(11):1432-42. doi: 10.1016/j.euroneuro.2013.02.006. Epub 2013 Apr 3.
6
Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.扩展酒精依赖的治疗选择：按需纳美芬的随机对照研究。
Biol Psychiatry. 2013 Apr 15;73(8):706-13. doi: 10.1016/j.biopsych.2012.10.020. Epub 2012 Dec 11.
7
Barriers and bridges to evidence based clinical practice.循证临床实践的障碍与桥梁
BMJ. 1998 Jul 25;317(7153):273-6. doi: 10.1136/bmj.317.7153.273.